Golden State Equity Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$85.7K Buy
+993
New +$82.6K 0.01% 886
2026
Q2
– Sell
-396
Closed -$24.9K – 723
2026
Q1
$24.9K Buy
+396
New +$27.6K ﹤0.01% 1045
2024
Q4
– Sell
-600
Closed -$40.2K – 567
2024
Q3
$40.2K Buy
+600
New +$49.3K 0.01% 562

Other funds holding DXCM

Golden State Equity Partners's DXCM Position: Q3 2026 in Review

Golden State Equity Partners opened a new position in DexCom (DXCM) in Q3 2026: 993 shares worth $85.7K. The stake represents 0.01% of the portfolio and ranks #886 among its holdings. This is a return to the name: Golden State Equity Partners previously reported a position in DXCM as recently as Q1 2026.

Golden State Equity Partners first reported a position in DXCM in Q3 2024 and has held it in 3 quarters since. 1,054 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Golden State Equity Partners held 993 shares of DexCom worth $85.7K as of Q3 2026.
  • DexCom was a new Golden State Equity Partners position in Q3 2026.
  • DexCom made up 0.01% of Golden State Equity Partners's portfolio in Q3 2026, its #886 holding.
  • Golden State Equity Partners first reported a position in DexCom in Q3 2024 and has held it in 3 quarters since.
  • 1,054 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Golden State Equity Partners's 13F filing for Q3 2026, filed 3 Nov 2026.